[CLDX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 7.37%
YoY- 7.45%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 3,829 1,534 1,874 2,220 1,389 1,303 1,790 66.09%
PBT -28,566 -34,261 -32,307 -29,598 -31,952 -34,673 -32,684 -8.59%
Tax 1,276 5,098 -5,090 -790 -828 -2,062 836 32.59%
NP -28,566 -34,261 -32,307 -29,598 -31,952 -34,673 -32,684 -8.59%
Tax Rate - - - - - - - -
Total Cost 32,395 35,795 34,181 31,818 33,341 35,976 34,474 -4.06%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -746.04 -2,233.44 -1,723.96 -1,333.24 -2,300.36 -2,661.01 -1,825.92 -44.96%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -3.42 -4.19 -4.49 -4.41 -4.85 -5.27 -4.97 -22.07%
EPS Diluted -3.42 -4.19 -4.49 -4.41 -4.85 -5.27 -4.97 -22.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.